Best practices in RF ablation yield excellent outcomes for atrial fibrillation patients

FHS
May 20, 2024
10:56 am

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone.

Opinion | ‘A Real Regulatory Dilemma Here’: What We Heard This Week

“It’s a real regulatory dilemma here.” — Donald Kohn, MD, of the University of California Los Angeles, at an FDA advisory committee meeting to discuss

November 25, 2024

Hoba, a Danish biotech from Novo, raises $25M to crack into difficult pain and hearing loss fields

Novo Holdings-founded biotech Hoba Therapeutics has raised $25 million in the first close of a Series A financing to bankroll its investigational medicines for pain

December 12, 2023

Abivax announces the filing of an amended registration statement, including an estimated initial public offering price range – Biotech Investments

EQS-News: ABIVAX / Key word(s): IPO Abivax announces the filing of an amended registration statement, including an estimated initial public offering price range 19.10.2023 /

October 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.